PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Dumas receives funding for study of how distinct NMDA receptor signaling domains regulate hippocampal network dynamics

2024-08-27
(Press-News.org)

Dumas Receives Funding For Study Of How Distinct NMDA Receptor Signaling Domains Regulate Hippocampal Network Dynamics

Theodore Dumas, Associate Professor, Psychology, College of Humanities and Social Sciences (CHSS), received funding for the project: “Distinct NMDA receptor signaling domains regulate hippocampal network dynamics.

Dumas and his collaborators hypothesize that in wildtype mice, NMDA receptors regulate hippocampal network oscillatory activity (slow gamma frequency) in the absence of ion conductance (nonionotropic) and that enhancing GluN2B subunit-type nonionotropic signaling will increase slow gamma power and enhance spatial memory retrieval.

The researchers will test these hypotheses by assessing slow gamma oscillations (and coupling with other pertinent oscillatory bands), particularly during immobility prior to movement to a known goal location, and spatial memory accuracy in mice expressing chimeric GluN2 subunits in: 1) forebrain principal cells, 2) hippocampal principal cells, or 3) hippocampal parvalbumin-positive (PV+) interneurons.

This study is the first of its kind to differentiate the roles of two separate NMDA receptor signaling streams in the regulation of hippocampal network activity and spatial memory retrieval. Outcomes from this study will explain why treatments for schizophrenia directed at NMDA receptors in general are only moderately effective and will identify more specific therapeutics targets.

Dumas received $231,547 from the National Institutes of Health for this project. Funding began in Aug. 2024 and will end in late July 2026.

###

ABOUT GEORGE MASON UNIVERSITY

George Mason University is Virginia’s largest public research university. Located near Washington, D.C., Mason enrolls more than 40,000 students from 130 countries and all 50 states. Mason has grown rapidly over the past half-century and is recognized for its innovation and entrepreneurship, remarkable diversity, and commitment to accessibility. In 2023, the university launched Mason Now: Power the Possible, a one-billion-dollar comprehensive campaign to support student success, research, innovation, community, and stewardship. Learn more at gmu.edu.

END



ELSE PRESS RELEASES FROM THIS DATE:

Second genetic sensor for DNA methylation discovered

2024-08-27
DNA methylation is a process in which a methyl group is attached to the cytosine base of the DNA molecule, and a major way that DNA is epigenetically marked. Epigenetic modifications can act as on-off switches to regulate gene expression and help generate diverse cell types without changing the underlying DNA sequence. It is how the body ensures that brain-related genes don’t get turned on in heart cells, for example. For this reason, maintenance of the DNA methylation pattern is important to ensure the correct and consistent function of each cell type. But this is no easy feat: the DNA methylation pattern can change over time, and this is linked to a variety of diseases. One ...

New sensor technology enhances detection of tiny particles

New sensor technology enhances detection of tiny particles
2024-08-27
In recent years, advances in photonics and materials science have led to remarkable developments in sensor technology, pushing the boundaries of what can be detected and measured. Among these innovations, non-Hermitian physics has emerged as a crucial area of research, offering new ways to manipulate light and enhance sensor sensitivity. A recent study published in Advanced Photonics Nexus reports a breakthrough in this field, presenting a new type of sensor that leverages exceptional points (EPs) to achieve unprecedented levels of sensitivity. This study introduces a highly sensitive and reconfigurable sensor based on a single ...

New technology ‘lights up’ bacteria in wounds for better infection prevention

New technology ‘lights up’ bacteria in wounds for better infection prevention
2024-08-27
LOS ANGELES — Over 6.5 million Americans experience chronic wounds — wounds that do not heal after a few months. Almost all such wounds contain bacteria, which, if not detected and removed, can lead to severe infection and resulting complications, including amputation if a limb is involved.  This is especially true for patients with diabetic foot ulcers (open sores), which affects one-third of people with diabetes. Approximately 20% of those who develop a diabetic foot ulcer will require a lower-extremity amputation, according ...

UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy

UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy
2024-08-27
UCLA has received a $120 million commitment from surgeon, inventor and philanthropist Dr. Gary Michelson and his wife, Alya, to kick-start the California Institute for Immunology and Immunotherapy, an innovative public-private partnership aimed at spurring breakthrough discoveries that prevent and cure diseases and catalyze economic growth and innovation in Los Angeles.  Michelson, a spine surgeon and prolific inventor who holds nearly 1,000 individual patents, is co-founder and chair of the board of the institute, which will be housed at UCLA’s state-of-the-art research park. The gift, distributed via ...

Dunick receives funding for Center For Economic Education

2024-08-27
Dunick Receives Funding For Center For Economic Education Jason Dunick, Associate Chair and Term Associate Professor, Economics, College of Humanities and Social Sciences (CHSS), received $108,692 from Virginia Council on Economic Education for: “Center for Economic Education.” Dunick will use this funding to support the continuation of the services of the Center for Economic Education. The Center supports K-12 teachers who are teaching economics and personal finance in Virginia. This grant represents the renewal of a long-standing relationship with the ...

National Institutes of Health awards $2.4 million grant to cross-disciplinary team of researchers to study psychedelics for methamphetamine addiction

2024-08-27
FOR IMMEDIATE RELEASE Media Contacts: Colleen McDonald Sr. Consultant, Earned Media Kara Reed Director of Development Lisa Babin Executive Director of Communications Medical College of Wisconsin University of California San Diego LSU Health Shreveport  414.801.3146 | cmcdonald@mcw.edu 217.390.6629 | k3hendrickson@ucsd.edu 318.675.8769 | lisa.babin@lsuhs.edu   Milwaukee, Wis., August 27, 2024 – John McCorvy, PhD, Assistant Professor in the Department ...

Trioxidized cysteine and aging: Beyond proteinopathic paradigms

Trioxidized cysteine and aging: Beyond proteinopathic paradigms
2024-08-27
“The results indicated a significant increase in cumulative t-Cys levels and the total number of t-Cys residues in aging and aged mice proteomes compared to young groups.” BUFFALO, NY- August 27, 2024 – A new research perspective was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, Issue 15 on July 25, 2024, entitled, “Trioxidized cysteine and aging: a molecular binomial that extends far beyond classical proteinopathic paradigms.” Oxidative stress (OS) - characterized by an imbalance between oxidants and antioxidants - leads to the formation ...

Artificial intelligence: Revolutionizing precision oncology

Artificial intelligence: Revolutionizing precision oncology
2024-08-27
“Properly leveraged AI-based techniques could herald a new era of precision medicine guided by non-invasive, imaging-based disease evaluation." BUFFALO, NY- August 27, 2024 – A new editorial was published in Oncotarget's Volume 15 on August 26, 2024, entitled, “Artificial intelligence: A transformative tool in precision oncology.” Artificial intelligence (AI) is revolutionizing society and healthcare, opening new possibilities for precision medicine. In oncology, immunotherapy (IO) has similarly transformed cancer treatment with novel ...

How much microplastic are you drinking? New UBC tool can tell you in minutes

How much microplastic are you drinking? New UBC tool can tell you in minutes
2024-08-27
Micro- and nanoplastics are in our food, water and the air we breathe. They are showing up in our bodies, from testicles to brain matter. Now, University of British Columbia researchers have developed a low-cost, portable tool to accurately measure plastic released from everyday sources like disposable cups and water bottles. The device, paired with an app, uses fluorescent labeling to detect plastic particles ranging from 50 nanometres to 10 microns in size – too small to be detected by the naked eye – and delivers results in minutes. The method and findings are detailed in ACS Sensors. “The breakdown of larger plastic pieces into microplastics ...

Race and ethnicity and diagnostic testing for common conditions in the acute care setting

2024-08-27
About The Study: White patients discharged from the emergency department with a nonspecific diagnosis of interest were significantly more likely than Black patients to receive related diagnostic testing in this study. The extent to which this represents diagnostic test overuse in white patients vs undertesting and missed diagnoses in Black patients deserves further study.  Corresponding Author: To contact the corresponding author, Michael I. Ellenbogen, M.D., email mellenb6@jhmi.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.30306) Editor’s ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

[Press-News.org] Dumas receives funding for study of how distinct NMDA receptor signaling domains regulate hippocampal network dynamics